Asgard Therapeutics AB
559184-0136ActivePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Overview
- 10–19
- Employees
- ≤1K SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Cristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
+26 more contacts in Funnelfeedr
Description
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559184013601
Decision Makers
30 contacts in FunnelfeedrCristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
Nadiya Ishnazarova
Board Member
Xiaoli Huang
Project Director Preclinical Pharmacology
Ignacio Melero
Advisory Board Member
Johanna Olweus
Scientific Advisory Board Member
Shane Olwill
Chief Development Officer
João Ribas
Board Member
Jan Villadsen
Head of Finance
Ulrich Lauer
Advisory Board Member
Jonas Jendi
Board Member
Martin Bonde
Chair of the Board
Joshua Brody
Advisory Board Member
Fiona MacLaughlin
Board Member (Johnson & Johnson Innovation – JJDC, Inc.)
Brian Brown
Advisory Board Member
Aleksei Zeifman
Board Member (RV Invest)
Filipe Pereira
Co-founder and Head of Innovation
Frank Hennecke
Head of CMC
Wolfram Brugger
Chief Medical Officer
Aurélien Marabelle
Advisory Board Member
Cristina Csimma
Independent Board Member
Julie M Cherrington
Advisory Board Member
Other Contacts
Iveta Mikalajūnaitė
Team Member
Xavier Catena
Team Member
Emilie Renaud
Team Member
André Rosa
Team Member
+2 more contacts in Funnelfeedr
Similar Companies
20 similar companies in FunnelfeedrSACRA Therapeutics AB
0 employeesSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Anocca AB
100–199 employeesEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Lokon Pharma AB
10–19 employeesDeveloping novel gene engineering vectors for cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Theralia AB
0 employeesPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Browse More
Asgard Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo